TP53 and cancer: The results show that the slight cell death effect of ADR or CDDP and CPS alone was significantly increased when the chemotherapeutic drugs were used in combination with CPS (Fig. 5), suggesting that CPS-induced p53 reactivation may improve mutp53-carrying cancer cell response to chemotherapy.